Improving Human and Planetary Health
Total Page:16
File Type:pdf, Size:1020Kb
AKER BIOMARINE IMPROVING HUMAN AND PLANETARY HEALTH ANNUAL REPORT 2020 AKER BIOMARINE IS A BIOTECH INNOVATOR AND ANTARCTIC KRILL-HARVESTING COMPANY, DEDICATED TO IMPROVING HUMAN AND PLANETARY HEALTH. CONTENTS 4 HIGHLIGHTS 5 2020 KEY FIGURES 13 CEO LETTER 15 THIS IS US 26 COVID HANDLING 28 OUR PRODUCTS 37 ENVIROMENTAL, SOCIAL, GOVERNANCE 50 FINANCE 4 2020 KEY FIGURES Aker BioMarine is a biotech innovator and Antarctic krill-harvesting company, dedicated to improving human and planetary health. Aker BioMarine’s fully transparent value chain stretches from sustainable krill harvesting in pristine Antarctic waters through its Montevideo logistics hub, Houston production plant, and to customers around the world. Admitted to trading on Euronext Growth, Aker BioMarine consists of two business segments, Ingredients and Brands. Under Ingredients, the company develops krill-based ingredients for human applications in the nutraceutical and dietary supplement space, and animal feed applications for aquaculture and pet food. Under Brands, Aker BioMarine has two companies, Lang Pharma Nutrition and Epion Brands. Lang Pharma Nutrition is a full service, mass market private label and corporate brand manufacturer within supplements, based in the U.S. with large U.S. retailers as its primary customers. Epion Brands has launched a consumer brand, Kori in the U.S. market, being on the shelves of major retailers. Aker BioMarine’s strong focus on sustainability inspired the launch of AION by Aker BioMarine, a circularity company dedicated to helping companies to recycle and reuse waste. PEOPLE PRODUCTS Women in 1.6 Executive billion doses of Superba Krill sold worldwide Gender Management balance Team 40 410 551 million extra servings of fish Number 24% Number of 40% of different 1.6 employees nationalities million dogs ate QRILL Pet that improves health and performance 65 countries receive Aker BioMarine products 5 REVENUE AND ADJUSTED EBITDA DEVELOPMENT REVENUE ADJUSTED EBITDA AND MARGIN 2018-2020 2018-2020 (USD million) 288.6 (USD million) 78 246.2 53 154.2 39 25.3% 21.5% 27.1% 2018 2019 2020 2018 2019 2020 6 THE PLANET AND AKER BIOMARINE 1% PRECAUTIONARY KRILL QUOTA IN AREA 48 2010-2025 CERTIFIED AS SUSTAINABLE BY MSC / MSC RECERTIFIED IN 2020 SFP “A” RATING SIX YEARS IN A ROW AWR SURPASSES USD 1 MILLION FOR ANTARCTIC SCIENCE PROJECTS ENHANCED VOLUNTARY COMMITMENT BY CLOSING 4500 KM2 TO PROTECT ANTARCTIC OCEAN ALL-YEAR AION IS ONE OF THREE NORWEGIAN COMPANIES WITH B-CORP CERTIFICATION AION IS PART OF THE 1% FOR THE PLANET INITIATIVE WHERE 1% OF THE COMPANY’S REVENUE IS DONATED TO CAUSES THAT ARE GOOD FOR NATURE 2,64 TONNES CO2 PER TONNE KRILL PRODUCED* *In previous years, we have reported tonne CO2 per tonne krill caught. For 2020 and going forward, we will report on tonne CO2 per tonne krill produced because it more accurately reflects our company operations. 7 8 KEY MILESTONES From stock listing to new product launches, here are some of the highlights from 2020. NOVEL PROTEIN CIRCULARITY COMPANY In early 2021, Aker Aker BioMarine launched BioMarine launched AION, a new company INVI™, a hydrolyzed that will use a capital light protein isolate with a and technology agnostic complete amino acid business model to offer profile, that is also rich products and services to in minerals, including companies with a desire to STOCK LISTING calcium and magnesium. BRAIN AND EYE HEALTH recycle waste and re-use materials. On July 6th, Aker Aker BioMarine launched BioMarine's shares were LYSOVETA™, a new admitted to trading on delivery platform based on Euronext Growth (previous LPC-bound EPA and DHA name was Merkur Market). from krill. This will open The Company will proceed up new opportunities and with a listing on the Oslo new large markets within Stock Exchange ("OSE") in the brain, eye and other April 2021. important health areas. 9 EXPANSION IN INDIA MSC RE-CERTIFICATION Aker BioMarine Aker BioMarine received continues to invest in its third consecutive India by establishing a certification with no new distribution hub conditions from the in Chennai, to keep the Marine Stewardship region well-stocked with Council (MSC) for its its QRILL Aqua products. sustainable Antarctic ANTARCTIC PROVIDER QRILL APPROVAL IN CHINA krill fishery following an Aker BioMarine celebrated Aker BioMarine obtained independent assessment. the launch of its new, market access to the Chinese The company was initially state-of-the-art support market for QRILL Aqua and certified in 2010, being the vessel at the ceremony at QRILL Pet. This was a very first krill company ever to CIMC Raffles’ Yantai yard. important milestone for the carry the MSC label. The vessel will replace commercial development of Aker BioMarine’s existing the Chinese market for support vessel, La Manche. QRILL products. 10 INDUSTRY ALLIANCE ANTARCTIC SCIENCE Aker BioMarine joined The Antarctic Wildlife forces with The Bellona Research Fund (AWR) Foundation, the Norwegian announced its 7th call for Seafood Federation and proposal and surpassed the six other major players milestone of USD 1 million in the fish feed industry devoted to Antarctic science to improve the climate projects since the launch of “A” RATING footprint of Norwegian PENGUIN PROTECTION the organization in 2015. For the sixth year in a row, the salmon. An NGO-industry krill fishery received an “A” collaboration to protect rating for its well-managed the Antarctic Ocean fishery from the Sustainable announced a big step Fisheries Partnership (SFP). forward with a year-round The independent report states closure of a 4 500km2 that the fish stocks are listed area of ocean around in “very good condition” and Hope Bay in the northern the Antarctic krill fishery is Antarctic Peninsula. This once again singled out as being is an enhancement of the particularly well-managed. ARK seasonal closures established in 2018. 11 DOG HEALTH SHRIMP HEALTH A new study with 20 A new study demonstrated Alaskan Huskies showed that astaxanthin krill oil that the dogs that received can result in a significant QRILL Pet AstaOmega Oil advantage for the Pacific experienced a significant whiteleg shrimp in the increase in their levels of post-larval stage. Through EPA and DHA, ensuring the use of growth- KRILL HEALTH BENEFITS overall health of dogs. SALMON HEALTH enhancing astaxanthin A new study by Aker The Norwegian Institute krill oil in the post-larval BioMarine, in partnership of Food, Fisheries and diet, the production cycle with the Oslo University Aquaculture (Nofima), in can be shortened, and Hospital, showed that collaboration with Aker mortality reduced, even the consumption of krill BioMarine, released a under stressful conditions. oil prior to endurance study that reveals that competitions increases krill meal improved the levels of circulating welfare and fillet quality of choline and its metabolites the salmon. in athletes. 12 One important aspect of Aker BioMarine’s culture is “Can do and grind through”. We saw this element of our strong culture in action during the pandemic, as all employees rolled up their sleeves and pushed through until our shared targets were met. - Matts Johansen CEO, Aker BioMarine 13 2020 WAS A TRUE “CAN DO AND GRIND THROUGH” YEAR Record year despite Covid-19 and operational challenges he year 2020 may well be remembered Our at-sea crew originates from locations A YEAR OF INNOVATIONS to more sustainable operations, we plan to as one of the most challenging years in around the world, and border closures and continuously raise the bar. Aker BioMarine 2020 was also the year in which two of recent history, but for Aker BioMarine, limited flight availability represented a real intends to be a frontrunner in setting T our innovations that had been under last year marked another record year. We challenge to our ability to transport people. a sustainability agenda in cooperation development were finally ready to be grew our topline by 17% to USD 289 million Thanks to a strong collaborative effort across with partners. We are launching our new revealed. At Aker BioMarine, innovation and we grew our adjusted EBITDA by 47% to the company, one that put people first in ESG platform including new, ambitious, is deeply anchored in our culture and our USD 78 million. At year-end, we clearly saw every decision, we succeeded in transferring industry-leading goals for sustainable processes, and in 2020, we gave the world a the results of what we in Aker BioMarine call our crew and keeping our vessels free of operations. These goals will help us to taste of that innovative power. During the ‘operational leverage’, meaning that since infection. While these efforts came with continue our mission to improve human and year we launched LYSOVETA, a new molecule most of our costs are fixed, topline growth significant costs and responsibilities beyond planetary health, as well as to show the way that delivers EPA and DHA through the enables our profitability to grow even faster. the ordinary, our employees proved their and inspire other businesses. blood brain barrier, designed to positively For us, growth always has been a key focus, dedication and passion for what we do as impact cognitive and eye health. With and it will continue to be so in the years to a company by both upholding the strict our pole position, our competitive cost STRONG CULTURE ENSURING TARGET come. quarantine rules and being flexible with the profile, strong IP estate and an enormous FULFILMENT 2020 was also a year of learning and length of their stay at-sea. addressable market, we are looking at the One important aspect of Aker BioMarine’s overcoming challenges for Aker BioMarine, Our harvesting operation also faced its biggest opportunity since the start of Aker culture is “Can do and grind through”. This specifically related to the Covid-19 share of challenges in 2020.